United Arab Emirates

8 Vaccines Approved for Use in United Arab Emirates

Protein Subunit

National Vaccine and Serum Institute

Recombinant SARS-CoV-2 Vaccine (CHO Cell)

Approved in 1 country
3 trials in 2 countries
Approval Source: scmp.com
RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Approval Source: reuters.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik Light

Approved in 26 countries
6 trials in 2 countries
Approval Source: tass.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: cnbc.com
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: u.ae
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
29 trials in 12 countries
Approval Source: nature.com
Inactivated

Valneva

VLA2001

Approved in 2 countries
6 trials in 3 countries
Approval Source: valneva.com

7 in Clinical Trials in United Arab Emirates

Protein Subunit

National Vaccine and Serum Institute

Recombinant SARS-CoV-2 Vaccine (CHO Cell)

Approved in 1 country
3 trials in 2 countries
Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
15 trials in 12 countries
Protein Subunit

Sinocelltech

SCTV01C

12 trials in 2 countries
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Inactivated

Sinopharm (Wuhan)

Inactivated (Vero Cells)

Approved in 2 countries
9 trials in 7 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
29 trials in 12 countries